Expression of gonadotropin and activin receptor messenger ribonucleic acid in human ovarian epithelial neoplasms

Clinical Cancer Research

Volumn 6, Issue 7, 2000, Pages 2764-2770

  Minegishi, Takashi ^a   Kameda, Takashi ^a   Hirakawa, Takashi ^a   Abe, Kazuko ^a   Tano, Mari ^a   Ibuki, Yoshito ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; ACTIVIN RECEPTOR; FOLLITROPIN RECEPTOR; GONADOTROPIN; GONADOTROPIN RECEPTOR; LUTEINIZING HORMONE RECEPTOR;

ARTICLE; BIOSYNTHESIS; CANCER GROWTH; CARCINOGENESIS; CONTROLLED STUDY; EPITHELIUM TUMOR; GENE EXPRESSION; HUMAN; HUMAN TISSUE; OVARY TUMOR; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UNIVERSITY HOSPITAL;

ACTIVIN RECEPTORS; ACTIVINS; ADULT; AGED; BLOTTING, NORTHERN; CARCINOMA; FEMALE; HUMANS; INHIBINS; MIDDLE AGED; OVARIAN NEOPLASMS; RECEPTORS, GONADOTROPIN; RECEPTORS, GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 0033910864     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Biskind, M. S., and Biskind, G. S. Development of tumors in the rat ovary after transplantation into the spleen. Proc. Soc. Exp. Biol. Med., 55: 176-179, 1994.
2. Cramer, D. W., and Welch, W. R. Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. J. Natl. Cancer Inst., 71: 717-721, 1983.
3. Jindal, S. K., Ishii, E., Letarte, M., Vera, S., Teerds, K. J., and Dorrington, J. H. Regulation of transforming growth factor α gene expression in an ovarian surface epithelial cell line derived from a human carcinoma. Biol. Reprod., 52: 1027-1037, 1995.
4. Hamilton, T. C. Ovarian cancer. Part I: biology. Curr. Probl. Cancer, 16: 1-57, 1992.
5. Kruk, P. A., Maines Bandiera, S. L., and Auersperg, N. A simplified method to culture human ovarian surface epithelium. Lab. Invest., 63: 132-136, 1990.
6. Hillier, S. G. Regulatory functions for inhibin and activin in human ovaries. J. Endocrinol., 131: 171-175, 1991.
7. Robertson, D. M., Foulds, L. M., Leversha, L., Morgan, F. J., Hearn, M. T., Burger, H. G., Wettenhall, R. E., and de Kretser, D. M. Isolation of inhibin from bovine follicular fluid. Biochem. Biophys. Res. Commun., 126: 220-226, 1985.
8. Vale, W., Rivier, J., Vaughan, J., McClintock, R., Corrigan, A., Woo, W., Karr, D., and Spiess, J. Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid. Nature (Lond.), 321: 776-779, 1986.
9. Ying, S. Y. Inhibins, activins, and follistatins: gonadal proteins modulating the secretion of follicle-stimulating hormone. Endocr. Rev., 9: 267-293, 1988.
10. Mathews, L. S. Activin receptors and cellular signaling by the receptor serine kinase family. Endocr. Rev., 15: 310-325, 1994.
11. Ohashi, M., Hasegawa, Y., Haji, M., Igarashi, M., and Nawata, H. Production of immunoreactive inhibin by a virilizing ovarian tumour (Sertoli-Leydig tumour). Clin. Endocrinol. Oxf., 33: 613-618, 1990.
12. Puls, L. E., Hamous, J., Morrow, M. S., Schneyer, A., MacLaughlin, D. T., and Castracane, V. D. Recurrent ovarian sex cord tumor with annular tubules: tumor marker and chemotherapy experience. Gynecol. Oncol., 54: 396-401, 1994.
13. Zheng, W., Sung, C. J., Hanna, I., DePetris, G., Lambert Messerlian, G., Steinhoff, M., and Lauchlan, S. C. Alpha and β subunits of inhibin/activin as sex cord-stromal differentiation markers. Int. J. Gynecol. Pathol., 16: 263-271, 1997.
14. Burger, H. G., and Fuller, P. J. The inhibin/activin family in ovarian cancer. Trends Endocrinol. Metab., 7: 197-202, 1996.
15. Cooke, I., O'Brien, M., Charnock, F. M., Groome, N., and Ganesan, T. S. Inhibin as a marker for ovarian cancer. Br. J. Cancer, 71: 1046-1050, 1995.
16. Lappohn, R. E., Burger, H. G., Bouma, J., Bangah, M., Krans, M., and de Bruijn, H. W. Inhibin as a marker for granulosa-cell tumors. N. Engl. J. Med., 321: 790-793, 1989.
17. Di Simone, N., Crowley, W. F., Jr., Wang, Q. F., Sluss, P. M., and Schneyer, A. L. Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation. Endocrinology, 137: 486-494, 1996.
18. Welt, C. K., Lambert Messerlian, G., Zheng, W., Crowley, W. F., Jr., and Schneyer, A. L. Presence of activin, inhibin, and follistatin in epithelial ovarian carcinoma. J. Clin. Endocrinol. Metab., 82: 3720-3727, 1997.
19. Heintz, A. P., Hacker, N. F., and Lagasse, L. D. Epidemiology and etiology of ovarian cancer: a review. Obstet. Gynecol., 66: 127-135, 1985.
20. Silverberg, E. Statistical and Epidemiological Information in Gynecologic Cancer. New York: American Cancer Society, 1986.
21. Whittemore, A. S., Harris, R., and Itnyre, J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. Am. J. Epidemiol., 136: 1184-1203, 1992.
22. Risma, K. A., Clay, C. M., Nett, T. M., Wagner, T., Yun, J., and Nilson, J. H. Targeted overexpression of luteinizing hormone in transgenic mice leads to infertility, polycystic ovaries, and ovarian tumors. Proc. Natl. Acad. Sci. USA, 92: 1322-1326, 1995.
23. Tapanainen, J. S., Tilly, J. L., Vihko, K. K., and Hsueh, A. J. Hormonal control of apoptotic cell death in the testis: gonadotropins and androgens as testicular cell survival factors. Mol. Endocrinol., 7: 643-650, 1993.
24. Godwin, A. K., Perez, R. P., Johnson, S. W., Hamaguchi, K., and Hamilton, T. C. Growth regulation of ovarian cancer. Hematol. Oncol. Clin. North Am., 6: 829-841, 1992.
25. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
26. Minegishi, T., Tano, M., Igarashi, M., Rokukawa, S., Abe, Y., Ibuki, Y., and Miyamoto, K. Expression of follicle-stimulating hormone receptor in human ovary. Eur. J. Clin. Invest., 27: 469-474, 1997.
27. Minegishi, T., Tano, M., Abe, Y., Nakamura, K., Ibuki, Y., and Miyamoto, K. Expression of luteinizing hormone/human chorionic gonadotrophin (LH/hCG) receptor mRNA in the human ovary. Mol. Hum. Reprod., 3: 101-107, 1997.
28. Knight, P. G., Muttukrishna, S., and Groome, N. P. Development and application of a two-site enzyme immunoassay for the determination of "total" activin-A concentrations in serum and follicular fluid. J. Endocrinol., 148: 267-279, 1996.
29. Attisano, L., Wrana, J. L., Cheifetz, S., and Massague, J. Novel activin receptors: distinct genes and alternative mRNA splicing generate a repertoire of serine/threonine kinase receptors. Cell, 68: 97-108, 1992.
30. Hino, M., Tojo, A., Miyazono, K., Miura, Y., Chiba, S., Eto, Y., Shibai, H., and Takaku, F. Characterization of cellular receptors for erythroid differentiation factor on murine erythroleukemia cells. J. Biol. Chem., 264: 10309-10314, 1989.
31. Mathews, L. S., and Vale, W. W. Expression cloning of an activin receptor, a predicted transmembrane serine kinase. Cell, 65: 973-982, 1991.
32. Russell, P. Effects of activin and follicle-stimulating hormone (FSH)-suppressing protein/follistatin on FSH receptors and differentiation of cultured rat granulosa cells. In: R. J. Kurman (ed.), Blaustein's Pathology of the Female Genital Tract, Ed. 4, pp. 705-782. New York: Springer-Verlag, 1994.
33. Scully, R. E. Tumors of the ovary and maldeveloped gonads. In: W. H. Hartmann and W. R. Cowan. (eds.), Atlas of Tumor Pathology, 2nd series, Fascicle 16, pp. 53-151. Washington, DC: Armed Forces Institute of Pathology, 1979.
34. Davy, M., Torjesen, P. A., and Aakavaag, A. Demonstration of an FSH receptor in a functioning granulosa cell tumour. The effect of gonadotrophin treatment on its viability following transplantation to nude mice. Acta Endocrinol., 85: 615-623, 1977.
35. Kammerman, S., Demopoulos, R. I., Raphael, C., and Ross, J. Gonadotropic hormone binding to human ovarian tumors. Hum. Pathol., 12: 886-890, 1981.
36. Nakano, R., Kitayama, S., Yamoto, M., Shima, K., and Ooshima, A. Localization of gonadotropin binding sites in human ovarian neoplasms. Am. J. Obstet. Gynecol., 161: 905-910, 1989.
37. Rajaniemi, H., Kauppila, A., Ronnberg, L., Selander, K., and Pystynen, P. LH (hCG) receptor in benign and malignant tumors of human ovary. Acta Obstet. Gynecol. Scand. Suppl., 101: 83-86, 1981.
38. Wardlaw, S., Lauersen, N. H., and Saxena, B. B. The lh-hcg receptor of human ovary at various stages of the menstrual cycle. Acta Endocrinol., 79: 568-576, 1975.
39. Simon, W. E., Albrecht, M., Hansel, M., Dietel, M., and Holzel, F. Cell lines derived from human ovarian carcinomas: growth stimulation by gonadotropic and steroid hormones. J. Natl. Cancer Inst., 70: 839-845, 1983.
40. Wimalasena, J., Dostal, R., and Meehan, D. Gonadotropins, estradiol, and growth factors regulate epithelial ovarian cancer cell growth. Gynecol. Oncol., 46: 345-350, 1992.
41. Kammerman, S., Demopoulos, R. I., and Ross, J. Gonadotropin receptors in experimentally induced ovarian tumors in mice. Cancer Res., 37: 2578-2582, 1977.
42. Shikone, T., Matzuk, M. M., Perlas, E., Finegold, M. J., Lewis, K. A., Vale, W., Bradley, A., and Hsueh, A. J. Characterization of gonadal sex cord-stromal tumor cell lines from inhibin-α and p53-deficient mice: the role of activin as an autocrine growth factor. Mol. Endocrinol., 8: 983-995, 1994.
43. Kojima, I., and Ogata, E. Dual effect of activin A on cell growth in Balb/c 3T3 cells. Biochem. Biophys. Res. Commun., 159: 1107-1113, 1989.
44. Rabinovici, J., Spencer, S. J., and Jaffe, R. B. Recombinant human activin-A promotes proliferation of human luteinized preovulatory granulosa cells in vitro. J. Clin. Endocrinol. Metab., 71: 1396-1398, 1990.
45. Yu, J., Shao, L. E., Lemas, V., Yu, A. L., Vaughan, J., Rivier, J., and Vale, W. Importance of FSH-releasing protein and inhibin in erythrodifferentiation. Nature (Lond.), 330: 765-767, 1987.
46. Berchuck, A., Rodriguez, G., Olt, G., Whitaker, R., Boente, M. P., Arrick, B. A., Clarke Pearson, D. L., and Bast, R. C., Jr. Regulation of growth of normal ovarian epithelial cells and ovarian cancer cell lines by transforming growth factor-β. Am. J. Obstet. Gynecol., 166: 676-684, 1992.
47. Bernstein, J. R., Crowley, W. F., Jr., and Schneyer, A. L. An improved method of purifying inhibin radioligand for radioimmunoassay. Biol. Reprod., 43: 492-496, 1990.
48. Fynan, T. M., and Reiss, M. Resistance to inhibition of cell growth by transforming growth factor-β and its role in oncogenesis. Crit. Rev. Oncog., 4: 493-540, 1993.
49. Hurteau, J., Rodriguez, G. C., Whitaker, R. S., Shah, S., Mills, G., Bast, R. C., and Berchuck, A. Transforming growth factor-β inhibits proliferation of human ovarian cancer cells obtained from ascites. Cancer (Phila.), 74: 93-99, 1994.
50. Roberts, A. B., Anzano, M. A., Wakefield, L. M., Roche, N. S., Stern, D. F., and Sporn, M. B. Type β transforming growth factor: a bifunctional regulator of cellular growth. Proc. Natl. Acad. Sci. USA, 82: 119-123, 1985.
51. Vale, W., Rivier, C., Hsueh, A., Campen, C., Meunier, H., Bicsak, T., Vaughan, J., Corrigan, A., Bardin, W., Sawchenko, P., Petraglia, F., Yu, J., Plotsky, P., Spiess, J., and Rivier, J. Chemical and biological characterization of the inhibin family of protein hormones. Recent Prog. Horm. Res., 44: 1-34, 1988.
52. Matzuk, M. M., Finegold, M. J., Su, J. G., Hsueh, A. J., and Bradley, A. α-Inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature (Lond.), 360: 313-319, 1992.
53. Matzuk, M. M., Finegold, M. J., Mather, J. P., Krummen, L., Lu, H., and Bradley, A. Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. Proc. Natl. Acad. Sci. USA, 91: 8817-8821, 1994.
54. Nakamura, M., Minegishi, T., Hasegawa, Y., Nakamura, K., Igarashi, S., Ito, I., Shinozaki, H., Miyamoto, K., Eto, Y., and Ibuki, Y. Effect of an activin A on follicle-stimulating hormone (FSH) receptor messenger ribonucleic acid levels and FSH receptor expressions in cultured rat granulosa cells. Endocrinology. 133: 538-544, 1993.
55. Xiao, S., Robertson, D. M., and Findlay, J. K. Effects of activin and follicle-stimulating hormone (FSH)-suppressing protein/follistatin on FSH receptors and differentiation of cultured rat granulosa cells. Endocrinology, 131: 1009-1016, 1992.